Dimer Dissociation and Unfolding Mechanism of Coagulation Factor XI Apple 4 Domain: Spectroscopic and Mutational Analysis

Journal of Molecular Biology

Volumn 367, Issue 2, 2007, Pages 558-573

  Riley, Paul W ^a   Cheng, Hong ^b   Samuel, Dharmaraj ^b   Roder, Heinrich ^b,c   Walsh, Peter N ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b FOX CHASE CANCER CENTER   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

blood coagulation; CD; fluorescence; FXI; NMR; protein folding

Indexed keywords

BLOOD CLOTTING FACTOR 9; CYSTEINE; DIMER; GLUTAMINE; GUANIDINE; LEUCINE; MONOMER; MUTANT PROTEIN; PHENYLALANINE; PROTEIN SUBUNIT; SERINE;

AMINO ACID SUBSTITUTION; ANISOTROPY; ARTICLE; CIRCULAR DICHROISM; CONTROLLED STUDY; DIMERIZATION; DISSOCIATION CONSTANT; FLUORESCENCE ANALYSIS; LIGHT SCATTERING; MOLECULAR DYNAMICS; MUTATIONAL ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN FOLDING; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; PROTEIN STRUCTURE; PROTEIN VARIANT; PROTON NUCLEAR MAGNETIC RESONANCE; SPECTROSCOPY;

MALUS X DOMESTICA;

EID: 33847118925     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2006.12.066     Document Type: Article

References (39)

1. Walsh P.N., and Gailani D. Factor XI. In: Colman R.W., Hirsh J., Marder V.J., Clowes A.W., and George J.N. (Eds). Hemostasis and Thrombosis: Basic Principles and Clinical Practice. 5th edit. (2006), Lippincott Williams and Wilkins, Philadelphia (vol. Chapt. 12)
2. Fujikawa K., Legaz M.E., Kato H., and Davie E.W. The mechanism of activation of bovine factor IX (Christmas factor) by bovine factor XIa (activated plasma thromboplastin antecedent). Biochemistry 13 (1974) 4508-4516
3. Gailani D., and Broze Jr. G.J. Factor XI activation in a revised model of blood coagulation. Science 253 (1991) 909-912
4. Naito K., and Fujikawa K. Activation of human blood coagulation factor XI independent of factor XII. Factor XI is activated by thrombin and factor XIa in the presence of negatively charged surfaces. J. Biol. Chem. 266 (1991) 7353-7358
5. Papagrigoriou E., McEwan P.A., Walsh P.N., and Emsley J. Crystal structure of the factor XI zymogen reveals a pathway for transactivation. Nature Struct. Mol. Biol. 13 (2006) 557-558
6. Meijers J.C., Mulvihill E.R., Davie E.W., and Chung D.W. Apple four in human blood coagulation factor XI mediates dimer formation. Biochemistry 31 (1992) 4680-4684
7. Wolberg A.S., Morris D.P., and Stafford D.W. Factor IX activation by factor XIa proceeds without release of a free intermediate. Biochemistry 36 (1997) 4074-4079
8. Gailani D., Ho D., Sun M.F., Cheng Q., and Walsh P.N. Model for a factor IX activation complex on blood platelets: dimeric conformation of factor XIa is essential. Blood 97 (2001) 3117-3122
9. Kravtsov D.V., Monahan P.E., and Gailani D. A classification system for cross-reactive material-negative factor XI deficiency. Blood 105 (2005) 4671-4673
10. Meijers J.C., Davie E.W., and Chung D.W. Expression of human blood coagulation factor XI: characterization of the defect in factor XI type III deficiency. Blood 79 (1992) 1435-1440
11. Asakai R., Chung D.W., Ratnoff O.D., and Davie E.W. Factor XI (plasma thromboplastin antecedent) deficiency in Ashkenazi Jews is a bleeding disorder that can result from three types of point mutations. Proc. Natl Acad. Sci. USA 86 (1989) 7667-7671
12. Fujikawa K. Historical perspective of factor XI. Thromb. Res. 115 (2005) 441-450
13. Asakai R., Chung D.W., Davie E.W., and Seligsohn U. Factor XI deficiency in Ashkenazi Jews in Israel. N. Engl. J. Med. 325 (1991) 153-158
14. Kravtsov D.V., Wu W., Meijers J.C., Sun M.F., Blinder M.A., Dang T.P., et al. Dominant factor XI deficiency caused by mutations in the factor XI catalytic domain. Blood 104 (2004) 128-134
15. Maki K., Cheng H., Dolgikh D.A., Shastry M.C., and Roder H. Early events during folding of wild-type staphylococcal nuclease and a single-tryptophan variant studied by ultrarapid mixing. J. Mol. Biol. 338 (2004) 383-400
16. Latypov R.F., Cheng H., Roder N.A., Zhang J., and Roder H. Structural characterization of an equilibrium unfolding intermediate in cytochrome c. J. Mol. Biol. 357 (2006) 1009-1025
17. Hobart S.A., Meinhold D.W., Osuna R., and Colon W. From two-state to three-state: the effect of the P61A mutation on the dynamics and stability of the factor for inversion stimulation results in an altered equilibrium denaturation mechanism. Biochemistry 41 (2002) 13744-13754
18. Haugland R. The Handbook-A Guide to Fluorescent Probes and Labeling Technologies. 10th edit (2006), Invitrogen, Inc., Carlsbad, CA
19. Jameson D.M., and Seifried S.E. Quantification of protein-protein interactions using fluorescence polarization. Methods 19 (1999) 222-233
20. Weber G. Protein Interactions (1992), Chapman and Hall, New York
21. Weber G. Energetics of ligand binding to proteins. Adv. Protein Chem. 29 (1975) 1-83
22. Jameson D.M., and Sawyer W.H. Fluorescence anisotropy applied to biomolecular interactions. Methods Enzymol. 246 (1995) 283-300
23. Privalov P.L. Intermediate states in protein folding. J. Mol. Biol. 258 (1996) 707-725
24. Sinha D., Marcinkiewicz M., Lear J.D., and Walsh P.N. Factor XIa dimer in the activation of factor IX. Biochemistry 44 (2005) 10416-10422
25. Myers J.K., Pace C.N., and Scholtz J.M. Denaturant m values and heat capacity changes: relation to changes in accessible surface areas of protein unfolding. Protein Sci. 4 (1995) 2138-2148
26. Sinha D., Marcinkiewicz M., Gailani D., and Walsh P.N. Molecular cloning and biochemical characterization of rabbit factor XI. Biochem. J. 367 (2002) 49-56
27. Jayandharan G., Shaji R.V., Nair S.C., Chandy M., and Srivastava A. Novel missense mutations in two patients with factor XI deficiency (Val271Leu and Tyr351Ser) and one patient with combined factor XI and factor IX deficiency (Phe349Val). J. Thromb. Haemost. 3 (2005) 808-811
28. Quelin F., Trossaert M., Sigaud M., Mazancourt P.D., and Fressinaud E. Molecular basis of severe factor XI deficiency in seven families from the west of France. Seven novel mutations, including an ancient Q88X mutation. J. Thromb. Haemost. 2 (2004) 71-76
29. Saunders R.E., O'Connell N.M., Lee C.A., Perry D.J., and Perkins S.J. Factor XI deficiency database: an interactive web database of mutations, phenotypes, and structural analysis tools. Hum. Mutat. 26 (2005) 192-198
30. Dorfman R., and Walsh P.N. Noncovalent interactions of the Apple 4 domain that mediate coagulation factor XI homodimerization. J. Biol. Chem. 276 (2001) 6429-6438
31. Rudolph R., Bohm G., Lilie H., and Janicke R. In: Creighton T.E. (Ed). Protein Function: A Practical Approach. 2nd edit. (1997), Oxford University Press, Oxford, UK
32. Saxena V.P., and Wetlaufer D.B. Formation of three-dimensional structure in proteins. I. Rapid non-enzymic reactivation of reduced lysozyme. Biochemistry 9 (1970) 5015-5023
33. 15N labeling of proteins for NMR studies. J. Biomol. NMR 5 (1995) 339-344
34. Scott C.P., Kashlan O.B., Lear J.D., and Cooperman B.S. A quantitative model for allosteric control of purine reduction by murine ribonucleotide reductase. Biochemistry 40 (2001) 1651-1661
35. Kashlan O.B., Scott C.P., Lear J.D., and Cooperman B.S. A comprehensive model for the allosteric regulation of mammalian ribonucleotide reductase. Functional consequences of ATP- and dATP-induced oligomerization of the large subunit. Biochemistry 41 (2002) 462-474
36. Goddard, T. D. & Kneller, D. G. (2004). Sparky 3, University of California, San Francisco.
37. 15N triple-resonance experiments. J. Magn. Reson. 87 (1990) 183-188
38. 13C-labeled proteins. J. Magn. Reson. 87 (1991) 620-627
39. 13C-labeled proteins. J. Magn. Reson. 91 (1991) 84-92